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The analytical quality by design approach has been previously applied to the method 
development. The analytical target profile (ATP) was defined as the baseline separation 
of the two analytes of interest, cannabidiol and Δ9-tetrahydrocannabinol. The critical 
method attributes (CMAs) were set as the critical resolution between a peak pair (Rs) 
and the analysis time (t). Critical method parameters were studied, and the response 
surface methodology was used to optimise the method. The method operable design 
region (MODR) was obtained by Monte-Carlo simulations and risk of failure maps 
setting the probability of meeting the specifications (Rs ≥ 0.85 and t ≤ 6 min) at 95%. A 
working point within the MODR was chosen, validated, and implemented in routine 
analyses. The information collected during the optimisation studies was conveyed to the 
planning of the control strategy consisting in system suitability test and control charts. 
The CMAs used for method optimisation were chosen as system suitability criteria to 
monitor the behaviour of the method performance. The evaluation was conducted over 
a period of one year of routine use. Both the CMAs showed values within the 
specifications in each analysis performed. On the basis of these results, a new and more 

















Main author: Deidda Riccardo 
Poster:  ☐ 
Oral presentation:  ☐ 
Thematic: 
• Target and drug discovery     ☐ 
• Biopharmaceutic(al)s      ☐ 
• Nanomedecine       ☐ 
• Personalized Medicine      ☐ 
• Methodological or technical developments   ☐ 
• Other         ☐ 
 
